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Summary.-The influence of vitamin A-related compounds on hyperplasia and
metaplasia induced by methylcholanthrene was studied in mouse prostate glands in
organ culture.
Methylcholanthrene was found to cause extensive hyperplasia and squamous
metaplasia of the prostatic epithelium which persisted after withdrawal of the
carcinogen.
The retinoids included retinoic acid and 6 of its structural analogues synthesized
in an attempt to enhance the anticarcinogenic action and reduce the toxicity of the
parent compound. These were the cyclopentenyl analogue 7699, A2-retinoic acid,
13-cis-a-retinoic acid and 3 aromatic analogues.
Administration of the compounds following the carcinogen reduced the extent
and incidence of hyperplasia significantly and with the exception of one compound
reversed the squamous metaplasia. Two of the aromatic analogues, one with a
terminal ethylamide group (1430), and the other with a terminal ethylester group
(9369), proved to be the most potent inhibitors, followed by compound 7699 and
retinoic acid. A2-retinoic acid and 13-cis-a-retinoic acid showed the lowest activity.
The inhibition of hyperplasia appeared to be mediated via a reduction of DNA
synthesis. It seemed unrelated to either the biological growth-promoting activity
of the compounds or their surface-active properties.
It is tentatively suggested that vitamin A and its analogues may act as hormones.
IT is now recognized that vitamin A
(retinol) is essential for growth, differen-
tiation and function ofsecretory epithelia.
In animals depleted in vitamin A, respira-
tory epithelia, salivary gland and pancreas
undergo squamous metaplasia (DeLuca
and Wolf, 1968; Hayes, McCombs and
Faherty, 1970; Kaufmann et al., 1972).
The male accessory sex organs, including
the prostate gland, show atrophy and
squamous metaplasia (Wolbach and Howe,
1925).
There is also mounting evidence that
the vitamin counteracts the action of
carcinogenic agents. In early work it
was discovered that retinol suppressed
the induction ofepithelial hyperplasia and
metaplasia by methylcholanthrene in
mouse prostate glands in vitro, and
reversed already established pre-cancerous
changes (Lasnitzki, 1955). The antago-
nism between vitamin A and carcinogen
was not confined to in vitro conditions but
has been confirmed in animal experiments.
In rats, vitamin A reduced methyl-
cholanthrene-induced squamous meta-
plasia and early tumours ofthe respiratory
tract (Cone and Nettesheim, 1973), in
hamsters, the vitamin inhibited the induc-
tion of lung tumours by benzopyrene
(Saffiotti et al., 1967) and the induction
of tumours of the forestomach and
cervix by dimethylbenzanthracene and
benzopyrene (Chu and Malmgren,
1965). Similarly, dimethylbenzanthracene-
induced skin tumours in mice and rabbits
were inhibited by retinoic acid (Bollag,
1972; Prutkin, 1973). This work hasI. LASNITZKI
been extended to clinical studies, which
have shown that premalignant and malig-
nant skin lesions and urinary bladder
papillomas partially or completely regress
after treatment with retinoic acid (Bollag
and Ott, 1970; Evard and Bollag, 1972).
The use of the vitamin as a potential
anti-tumour drug would be restricted by
its toxic side-effects at pharmacological
concentrations. So, in an attempt to
reduce the toxicity, a number of struc-
tural analogues of retinol and retinoic
acid have been synthesized.
Recent work (Lasnitzki and Goodman,
1974) has shown that 2 analogues of
retinoic acid, oc-retinoic acid and its
cyclopentenyl analogue, almost totally
abolished the induction of hyperplasia
and metaplasia by methylcholanthrene
in mouse prostate glands in organ culture.
It would be even more important to
establish whether the analogues would
reverse the changes already induced by the
carcinogen and restore a normal pattern
of growth. In the present experiments,
the influence of retinoic acid and 6 of its
structural analogues on the reversal of
precancerous changes has been investi-
gated in the same organ culture system,
in mouse prostates which had been pre-
treated with the carcinogen. The com-
pounds include retinoic acid, its cyclo-
pentenyl analogue, A2-retinoic acid, 13-
cis-oc-retinoic acid in which the side chain
has been modified, and 3 aromatic
analogues in which the cyclohexenyl ring
of retinoic acid has been replaced by a
trimethyl methoxyphenyl ring and the
terminal carboxyl group by either an
ethylester or ethylamide group.
MATERIAL AND METHODS
The prostate glands were obtained from
2-3-month-old C3H or R mice. Both ven-
tral and anterior or coagulating glands
were used. They were removed under
aseptic conditions and gently teased
apart into lobules measuring approximately
2 x 2 x 1 mm in size. Six to 8 of such
lobules were arranged on strips of lens-paper
and the strips placed on grids of extended
metal, resting in a small culture chamber.
The chambers were filled with semi-defined
liquid medium up to the level of the grids so
that it reached the explants by capillary
action. Two culture chambers were placed
in one Petri dish carpeted with moist filter
paper. For incubation, the Petri dishes
were stacked in an anaerobic McIntosh jar
and perfused with a mixture of 95% 02 and
5% C02 for 25 min at a flow rate of 125 ml/
min, which resulted in an 02 concentration
of 60% inside the jar.
Morgan, Morton and Parker's medium 199
(1950) supplemented with 15% foetal calf
serum was used.
3-Methylcholanthrene (MCA) (Koch-Light
Ltd., Colnbrook) was first dissolved in acetone
at a concentration of 2 mg/ml. A stock
solution of MCA in calf serum was prepared
by adding 0-06 ml of acetone containing
120 ,ug MCA to each ml of serum; 100 IlI of
this stock solution containing 12 Hg of MCA
was added to each 3 ml of culture medium so
that the final concentration amounted to
4 0 tg/ml.
The vitamin A compounds studied (reti-
noids, Fig. 1) were 3-retinoic acid, the cyclo-
pentenyl analogue R08-7699, A2-retinoic
acid R08-7057, 13-cis-ot-retinoic acid R08-
7201 and 3 aromatic analogues RO 10 1430,
1670, 9359. In these the cyclohexenyl ring
of retinoic acid had been replaced by a
trimethyl methoxyphenyl ring (TMMP) and
in 2 of them the terminal carboxyl group by
0
'-CH,1
la,l,00,,
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(.OOH
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X w< S~~~~~~~~~~~~11
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R = -CONHC2H5 1430
FIG. 1. Chemical structure of retinoic acid
and 6 of its analogues used in these experi-
ments.
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either an ethylester or an ethylamide group.
All compounds were a gift from Dr N. T.
Pollitt and Dr W. Bollag of Hoffman-La
Roche, Welwyn Garden City, England and
Basle, Switzerland. They were dissolved
in ethanol and stored under N2 in glass
ampoules at -25°C. Immediately before
each experiment a fresh ampoule was opened
and a given quantity of the solution added
to serum to produce a concentration of 9 ,g/
50 ,ul. To obtain lower concentrations, the
serum stock solution was further diluted with
culture medium.
The explants were exposed to MCA alone
for 10 days. Afterthis period, the carcinogen
was discontinued and the explants carried on
for a further 4 days either in control medium
or in medium containing retinoic acid or one
of the 6 analogues at concentrations ranging
from 0-3 to 3 0 jug/ml for all except the
aromatic compounds. Forthelatter, concen-
centrations of0-18 to 3 0 ,ug/ml were applied.
For histological examination, the explants
were fixed in Bouin's solution, dehydrated
in ascending alcohols, embedded in paraffin
wax and serially sectioned. The sections
were stained with haematoxylin-eosin.
The main criteria of effect used were the
persistence of epithelial hyperplasia and
squamous metaplasia recorded by light
microscopy.
Hyperplasia was defined as increased
proliferation of the cells lining the alveolar
lumen, leading to stratification. Squamous
metaplasia was defined as a change from the
original secretory cell type to a squamous
cell type.
The incidence of hyperplasia was quanti-
tated by counting all alveoli in alternate
sections of the explants, approximately 300
in each explant, and expressed as the percen-
tage of alveoli showing hyperplasia against
the total number counted. For each obser-
vation, 6-8 explants were used.
In each experiment, the percentage of
alveoli showing hyperplasia in explants
pretreated with MCA and carried on in control
medium for 4 days was assigned a value of
100%; the values obtained in explants trans-
ferred to medium containing the vitamin A
compounds were expressed as the percentage
hyperplasia relative to that seen in control
medium alone. Each bar in the figures
represents the mean relative percentage of
hyperplasia and its standard deviation.
The incorporation of 3H-thymidine by
the prostatic epithelium was determined by
autoradiography in explants pretreated with
the carcinogen and continued for 4 days in
control medium, and in explants pretreated
with the carcinogen and transferred for the
same period to medium containing retinoic
acid or the aromatic analogue 1430 contain-
ing the ethylamide group, applied in 2
concentrations. Theexplantswereincubated
for 5 h with 3H-thymidine, 1 juCi/ml (Radio-
chemical Centre, Amersham, sp. act. 109 mCi/
mg) and processed according to a method
previously described (Lasnitzki, 1969). In
each explant approximately 500 cells were
counted and the uptake was expressed as the
percentage of labelled cells out of the total
number. For each experimental group at
least 6 explants were used and the final result
expressed as the mean percentage and its
standard deviation.
RESULTS
Control8
Mouse prostate glands consist ofalveoli
and ducts separated by thin fibres offibro-
muscular stroma and lined with one row of
cuboidal or columnar secretory epithe-
lium. Occasionally, reserve cells can be
observed between the superficial cells and
the basement membrane. After culture,
the architecture of the tissue is preserved
but the epithelium has become reduced in
height.
Effect of methylcholanthrene
In explants exposed to MCA for 10
days and transferred to carcinogen-free
medium for a further 4 days, a substantial
number of alveoli exhibit extensive hyper-
plasia, while the stroma is sparse in cells
and fibres. The cells have multiplied
to form several layers, often amounting
to 10 rows projecting into or occluding
the alveolar lumen (Fig. 2). The hyper-
plasia is accompanied by a squamous
transformation ofthenewlyformedepithe-
lium: the original epithelium has been
shed and replaced by flat non-secretory
elements. These are surmounted by
several rows of transitional-type cells
connected with each other by tonofibrils
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and with basal-type cells of irregular size
displaying prominent nucleoli (Fig. 4).
The incidence ofhyperplasia amounted
to 51-69% of the total number of alveoli
counted.
Effect of retinoids
In the majority ofexplants transferred
to medium containing retinoic acid or its
structural analogues, the incidence and
extent of hyperplasia and squamous
metaplasia were strikingly reduced. In
contrast, the stroma appeared rich in
cells and fibres and, frequently, alveoli
could be seen surrounded by dense
connective tissue (Fig. 3). The degree
ofinhibition varied with the configuration
of the compounds and the concentrations
used. In explants treated with retinoic
acid, its cyclopentenyl analogue (7699)
and 2 of the aromatic analogues (1430
and 9359), the majority of alveoli were
either lined with one row of epithelium
(Fig. 5) or the hyperplasia was confined
to a few rows of cells. The hyperplastic
epithelium was usually columnar, fre-
quently formed secondary alveoli, and
developed into adenoma-like structures
(Fig. 6).
In explants exposed to A2-retinoic acid
(compound 7057) and to 13-cis-a-retinoic
acid (compound 7201), the hyperplasia
was less markedly reduced, and a sub-
stantial number ofalveoli displayed exten-
sive hyperplasia. The epithelium was
composed of crowded basal-like cells of
irregular size with prominent nucleoli
(Fig. 7).
The third aromatic compound bearing
a terminal carboxyl group (1670) was, at
the lower concentration, less efficient
than the other 2 in inhibiting cell
growth. In addition, unlike the other
2, it did not reverse the squamous
metaplasia, and explants treated with the
compound showed hyperplastic foci of
transitional or cornified cells (Fig. 8).
Figs. 9 and 10 quantitatively express
the inhibition of the MCA-induced hyper-
plasia seen after each of the 7 vitamin-A-
related compounds at concentrations rang-
ing from 0-18 to 3 0 /tg/ml medium. The
results are given as the percentage of
alveoli showing hyperplasia, relative to the
percentage seen in explants pretreated
with the carcinogen and transferred to
control medium, which is taken as 100%
(see Materials and Methods). Retinoic
acid and its cyclopentenyl derivative
(7699) inhibit the hyperplasia markedly
and to a similar degree, although at the
highest concentration the analogue seems
to be slightly more active. In contrast,
A2-retinoic acid and 13-cis-a-retinoic acid
are less effective: a dose of 1-5 ,ag/ml, for
instance, reduces the hyperplasia to only
70% of that seen in the controls, as
compared to 30% as determined for com-
pound 7699.
The aromatic analogues prove to be
highly efficient inhibitors (Fig. 10). The
2 analogues bearing the ethylamide
(1430) or the ethylester (9359) group are,
at all concentrations, more active than
retinoic acid, and at the lower concentra-
tions more effective than the third aroma-
tic analogue (1670) bearing the terminal
carboxyl group.
DNA synthesis
The reversal of hyperplasia may be
mediated via an inhibition by the retinoids
of DNA synthesis. This question was
explored in experiments in which the
FIG. 2. Section through mouse prostate gland grown for 10 days with MCA and continued in control
medium for 4 days, showing extensive hyperplasia and squamous metaplasia in most alveoli.
Haematoxylin-eosin, x 220.
FIG. 3. Section through similar gland grown for 10 days with MCA and continued for 4 days in
medium containing the aromatic analogue 9359 bearing a terminal ethylester group. The hyper-
plasia is slight and confined to a few alveoli. Note increased stroma around central alveolus.
Haematoxylin-eosin, x 220.
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FIG. 9.-The effects of retinoic acid, the cyclopentenyl analogue 7699, A2-retinoic acid and 13-cis-o-
retinoic acid on the reversal ofMCA-induced hyperplasia in mouse prostates in organ culture. The
vertical height of each bar gives the incidence of hyperplasia in explants treated with MCA for
10 days and continued for 4 days in medium containing the retinoids, as a percentage of the
incidence ofhyperplasia in explants pretreated with MCA and continued in control medium.
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FIG. 10. The effects of 3 aromatic analogues, 1430, 1670 and 9359 respectively, on the reversal of
MCA-induced hyperplasia in mouse prostates in organ culture. Interpretation as in Fig. 9.
FIG. 4. Hyperplastic alveolus from gland treated with MCA for 10 days and continued in control
medium, showing squamous metaplasia with shedding of parakeratotic cells. Haematoxylin-
eosin, x 350.
FIG. 5.-Alveolar lining epithelium from gland treated for 10 days with MCA and then exposed to
the aromatic compound 1430, bearing a terminal ethylamide group. There is complete absence of
hyperplasia and the epithelium is columnar and secreting. Haematoxylin-eosin, x 540.
FIG. 6. Hyperplastic epithelium from gland treated for 10 days with MCA and then exposed to
retinoic acid, demonstrating the reversal ofsquamous metaplasia. The epithelium is secretory, forms
secondary alveoli and has developed into an adenomatous structure. Haematoxylin-eosin, x 350.
FIG. 7.-Hyperplastic epithelium from gland treated for 10 days with MCA and then exposed to
A2-retinoic acid, consisting of crowded undifferentiated cells. Haematoxylin-eosin, x 410.
FIG. 8. Hyperplastic alveolus from gland treated for 10 days with MCA and then exposed to the
aromatic analogue 1670 bearing a terminal carboxyl group. The epithelium bas remained
squamous and consists of transitional and parakeratotic cells connected with tonofibrils. Haema-
toxylin-eosin, x 410.
245
T
i
I-I---II 1- 1---I---I. 1- 1. 1- L -1-I. LASNITZKI
25
Ct)
J
c0 C.)
20
15
10
5
n
MCA-CO
.35 .75 .575
MCA-RA MCA-AA1430
FIG. 11. Incorporation of 3H-thymidine in
mouse prostatic epithelium expressed as
the percentage of labelled cells (mean ±
s.d.), in explants pretreated with MCA and
continued in control medium (MCA-CO) or
medium containing retinoic acid (MCA-RA)
or the aromatic analogue 1430 (MCA-AA
1430).
incorporation of 3H-thymidine into the
prostatic epithelium was examined by
autoradiography. The effect of retinoic
acid and of the aromatic analogue 1430
was studied at concentrations of 0 35
and 0 75,ug/ml medium. The uptake of
the tracer was determined in explants
pretreated with MCA for 10 days and
transferred either to control medium or
medium containing either of the 2
retinoids. Fig. 11 shows that 25%
ofthe cells were labelled inexplants carried
on in control medium and that both reti-
noids halved this value. At the concen-
trations used, the reduction did not seem
to be dose-related.
DISCUSSION
MCA induces hyperplasia, dysplasia
and squamous metaplasia of the prostatic
epithelium, which persist after withdrawal
of the carcinogen. Recent work
(Lasnitzki, Bard and Franklin, 1975) has
shown that a substantial part of MCA is
retained, and presumably bound, by pros-
tatic tissue in vitro, even after several
changes of medium. This result may
explain the persistence ofthe precancerous
changesinthe absence ofadded carcinogen
All the retinoids examined reduce the
hyperplastic changes significantly, but
the degree of inhibition varies with their
structure. Thus A2-retinoic acid (7057)
and 13-cis-a-retinoic acid (7201) are con-
siderably less efficient than either retinoic
acid or its cyclopentenyl analogue 7699.
In contrast, the aromatic compounds
bearing the ethylamide (1430) or the
ethylester (9359) group are highly active
and even more potent inhibitors than
either retinoic acid or compound 7699.
Similar differences in activity have been
demonstrated by Bollag (1974, 1975),
who found that the 2 aromatic analogues
caused regression ofDMBA-induced mouse
papillomas at considerably lower concen-
trations than retinoic acid.
Theautoradiographic study shows that
retinoic acid, and the aromatic analogue
1430, depress the uptake of 3H-thymidine
by the prostatic epithelium and suggests
that the reversal ofhyperplasia is, at least
partially, mediated via a reduction of
DNA synthesis.
In addition to counteracting epithelial
cell proliferation, most of the compounds
abolish or modify the squamous changes
normally associated with the hyperplasia.
Retinoic acid, its cyclopentenyl analogue
7699 and 2 of the aromatic analogues,
fully restore the secretory character ofthe
epithelium; the hyperplastic epithelium,
if present, is composed ofcolumnar cells or
forms adenoma-like structures. A2-reti-
noic acid also suppresses the squamous
transformation, but does not induce secre-
tory epithelium: instead the cells remain
undifferentiated and present a basal-
cell-like appearance. The aromatic
analogue 1670, bearing a terminal car-
boxyl group, is the exception and does not
reverse the metaplasia; after a dose which
produces a similar degree ofgrowth inhibi-
tion to retinoic acid, the hyperplastic
epithelium remains squamous. These
results suggest that the inhibition of cell
growth may not be directly linked with the
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capacity ofthe retinoids to restore normal
epithelial differentiation.
Vitamin A is necessary for the support
of growth and life (Thompson, Howell
and Pitt, 1964). Of the compounds
studied here, retinoic acid possesses biolo-
gical growth-promoting activity, while
the cyclopentenyl analogue 7699, and the
aromatic analogue 1430, have virtually
none (Goodman et al., 1974; Bollag,
personal communication). Since all 3
compounds inhibit the MCA-induced
hyperplasia, it can be concluded that their
anti-carcinogenic properties are indepen-
dent of their biological growth-promoting
activity.
A substantial part of the carcinogen
remains bound to the tissue after transfer
to control medium (Lasnitzki et al., 1975)
and the retinoids may break this bond.
If so, a greater amount of free carcinogen
would be released from tissue exposed to
the vitamins. This expectation was not
realized: the release of tritiated MCA
from mouse prostatic tissue in vitro was of
the same order in the absence or presence
of retinoic acid (Lasnitzki and Goodman,
1974).
In vitro studies (Dingle and Fell,
1963) have shownthat vitamin Apromotes
the release of lysosomal enzymes. This
action is unrelated to the anti-carcinogenic
properties of the vitamin (Lasnitzki and
Goodman, 1974) but is most likely to
account for its toxicity. In cartilage,
the process results in the degradation of
the ground substance and loss of meta-
chromasia. In a companion study (Bard
and Lasnitzki, in preparation) the toxicity
of various retinoids has been investigated
using the release of S35-sulphate and loss
of metachromasia in rabbit ear cartilage
in vitro as a measure of toxicity. The
toxicity was found not to be related to the
ring structure of the compounds but to
their terminal group, and retinoids with a
carboxyl group, such as retinoic acid and
the aromatic analogue 1670, provoked
a high sulphate release, while analogues
with an ethylester or ethylamide group
were much less active.
There is recent evidence that in various
mammalian and avian tissues, retinoic
acid, the cyclopentenyl analogue 7699
and the aromatic analogues are bound to
specific proteins (Chityl and Ong, 1976;
Sani and Hill, 1976) and that the degree
of binding is related to the anticarcino-
genic property ofthe compounds and their
ability to inhibit keratinization. The
stability of the vitamin-protein complex
suggests that it may be a tissue receptor
(Sani and Hill, 1976). It is tempting to
speculate that like the steroid hormone
receptor complex the vitamin-protein
complex may also be transported into the
nucleus and bound to nuclear chromatin.
In this context it is interesting that in the
prostrate gland, vitamin A and testos-
terone show certain similarities of action.
Firstly, like the hormone, the retinoids
applied without the carcinogen maintain
epithelial height and secretory activity of
the prostatic epithelium (Lasnitzki and
Goodman, 1974). Secondly and more
importantly, testosterone has been found
to inhibit or suppress MCA-induced hyper-
plasia intherat prostate invitro (Lasnitzki
1965, 1970). Thus vitamin A resembles
a hormone in its ability to maintain secre-
tory epithelia and inhibit hyperplasia, and
the hormonal aspects of vitamin A
activity await further study.
I am greatly indebted to Dr N. T.
Pollitt and Dr W. Bollag of Hoffmann-
La-Roche, Welwyn Garden City, England
and Basle, Switzerland, for the gift of
the vitamin A compounds used in these
experiments. I should like to thank
Liesbet Brown for skilled technical assist-
ance, Peter Lancaster for the preparation
of the histograms and David Bard for
help with the microphotography.
The work was supported by the Cancer
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